{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-027413","form_type":"8-K","ticker":"BKYI","cik":"0001019034","company_name":"BIO KEY INTERNATIONAL INC","filed_at":"2022-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.251019+00:00","generated_at":"2026-06-21T17:59:24.786048+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BIO-key Q3 revenues up 6% to $1.4M, net loss widens to $2.4M; FY22 guidance cut to $7-9M","bullets":["Q3 revenue $1.4M (+6% YoY); YTD revenue $5.3M (+26%) on higher software and service fees.","Net loss $2.4M ($0.29/share) vs loss of $1.0M ($0.13) in Q3'21; SG&A up $1.1M.","Full-year 2022 revenue guidance lowered to $7M-$9M (37%-76% growth) citing slower sales and Africa delays.","Gross margin fell to 71% from 77% due to third-party software costs from Swivel Secure acquisition.","Cash $2.8M; current assets $9.9M; stockholders' equity $11.2M ($1.32/share) at Sept 30."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-027413","json":"https://secwatch.observer/filing/0001437749-22-027413.json","markdown":"https://secwatch.observer/filing/0001437749-22-027413.md","text":"https://secwatch.observer/filing/0001437749-22-027413.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1019034/000143774922027413/0001437749-22-027413-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1019034/000143774922027413/bkyi20221114_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T17:59:24.786048+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fcca36a247dea700db3a74cdd3d1d51ce1665f68","claim":"BIO KEY INTERNATIONAL INC reported third quarter ended September 30, 2022 results: revenue $1.4M, net income $2.4M, EPS $0.29 per share. Guidance lowered.","evidence_excerpt":"--- EX-99.1 (EXHIBIT 99.1) --- EX-99.1 2 ex_447392.htm EXHIBIT 99.1 ex_447392.htm Exhibit 99.1 Cyber-Security Provider BIO-key Reports Q3 and Year-to-Date Revenues Rose to $1.4M and $5.3M, Respectively, on Growing Software and Services Revenue; Investor Call Tomorrow at 10am ET WALL, NJ – November 14, 2022 - BIO-key ® International, Inc. (Nasdaq: BKYI),","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1019034/000143774922027413/0001437749-22-027413-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2022"},{"label":"Revenue","value":"$1.4M"},{"label":"Net income","value":"$2.4M"},{"label":"EPS","value":"$0.29 per share"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}